Contents

Current Drug Targets, Volume 16 - Number 7


Is there a Role for Bevacizumab in Non-Glial Tumors?

, 16(7): 684 - 688

Elisa Trevisan, Luca Bertero, Michela Magistrello, Roberta Ruda and Riccardo Soffietti


DOI: 10.2174/1389450116666150325230810



Mechanisms of bacterial acetohydroxyacid synthase (ahas) and specific inhibitors of Mycobacterium tuberculosis ahas as potential drug candidates against tuberculosis

, 16(7): 689 - 699

Kunal Gokhale and Bhargav Tilak


DOI: 10.2174/1389450116666150416115547



Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation

, 16(7): 700 - 710

Erin E. Witalison, Paul R. Thompson and Lorne J. Hofseth


DOI: 10.2174/1389450116666150202160954



Heterocyclic Scaffolds: Centrality in Anticancer Drug Development

, 16(7): 711 - 734

Imran Ali, Mohammad Nadeem Lone, Zeid A. Al-Othman, Abdulrahman Al-Warthan and Mohd. Marsin Sanagi


DOI: 10.2174/1389450116666150309115922




Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions

, 16(7): 747 - 756

Francesca Scicchitano, Andrew Constanti, Rita Citraro, Giovambattista De Sarro and Emilio Russo


DOI: 10.2174/1389450116666150330114850



Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets

, 16(7): 757 - 770

Annalisa Crema, Antonio Ponzetto, Massimo Clementi and Guido Carloni


DOI: 10.2174/1389450116666150213111603





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science